{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:29:48Z","timestamp":1786652988433,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol India"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/0028-3886.156281","type":"journal-article","created":{"date-parts":[[2015,5,5]],"date-time":"2015-05-05T04:29:55Z","timestamp":1430800195000},"page":"202","source":"Crossref","is-referenced-by-count":3,"title":["Critical appraisal of serum phenytoin variation with patient characteristics in a North Indian population"],"prefix":"10.4103","volume":"63","author":[{"given":"Sangeeta","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fauzia","family":"Tabassum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachna","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Bala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Baghel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritushree","family":"Kukreti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChandraB","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0028-3886.156281-1","first-page":"107","volume-title":"Adverse effects of antiepileptic drugs in North Indian pediatric outpatients","author":"Bansal","year":"2013","journal-title":"Clin Neuropharm"},{"key":"key-10.4103\/0028-3886.156281-2","first-page":"271","volume-title":"A clinical evaluation of therapeutic drug monitoring of PHT in epileptic patients in a tertiary care teaching hospital, Chennai, Tamil Nadu: A randomized, open label comparative study","author":"Sivasankari","year":"2012","journal-title":"Int J Pharma Bio Sci"},{"key":"key-10.4103\/0028-3886.156281-3","first-page":"1","volume-title":"Overview of therapeutic drug monitoring","author":"Kang","year":"2009","journal-title":"Korean J Intern Med"},{"key":"key-10.4103\/0028-3886.156281-4","first-page":"873","volume-title":"Effect of dosages increments on blood PHT concentration","author":"Bochner","year":"1972","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.4103\/0028-3886.156281-5","first-page":"73","volume-title":"Changes in drug metabolism with increasing age: 2.phenytoin clearance and protein binding","author":"Hayes","year":"1975","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.4103\/0028-3886.156281-6","first-page":"163","volume-title":"Phenytoin dose adjustment in epileptic patients","author":"Mawer","year":"1974","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.4103\/0028-3886.156281-7","first-page":"185","volume-title":"Therapeutic drug monitoring-antiepileptic drugs","author":"Eadie","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.4103\/0028-3886.156281-8","first-page":"24","volume-title":"Variability of serum PHT levels in critically ill head injured patients in intensive care unit","author":"Pillai","year":"2008","journal-title":"Indian J Crit Care Med","ISSN":"https:\/\/id.crossref.org\/issn\/0972-5229","issn-type":"print"},{"key":"key-10.4103\/0028-3886.156281-9","first-page":"534","volume-title":"Dosage recommendation of PHT for patients with epilepsy with different CYP2C9\/CYP2C19 polymorphisms","author":"Hung","year":"2004","journal-title":"Ther Drug Monit"},{"key":"key-10.4103\/0028-3886.156281-10","first-page":"93","volume-title":"The pharmacogenetics of CYP2C9 and CYP2C19: Ethnic variation and clinical significance","author":"Rosemary","year":"2007","journal-title":"Curr Clin Pharmacol"},{"key":"key-10.4103\/0028-3886.156281-11","first-page":"447","volume-title":"Genetic association analysis of transporters identifies ABCC2 loci for seizure control in women with epilepsy on first-line antiepileptic drugs","author":"Grover","year":"2012","journal-title":"Pharmacogenet Genomics"},{"key":"key-10.4103\/0028-3886.156281-12","first-page":"251","volume-title":"Effect of age, height, weight, and sex on serum PHT concentration in epileptic patients","author":"Houghton","year":"1975","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.4103\/0028-3886.156281-13","unstructured":"Porter RJ, Meldrum BS. Antiseizure Drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Katzung\u2032s Basic and Clinical Pharmacology. 11 th ed. India: McGraw-Hill; 2010. p. 404."},{"key":"key-10.4103\/0028-3886.156281-14","first-page":"132","volume-title":"The apparent clearance of free phenytoin in elderly vs.young adults","author":"Wright","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.4103\/0028-3886.156281-15","first-page":"971","volume-title":"The effect of combination therapy on the plasma concentrations of traditional antiepileptics: A retrospective study","author":"Sirmagul","year":"2012","journal-title":"Hum Exp Toxicol"},{"key":"key-10.4103\/0028-3886.156281-16","first-page":"88","volume-title":"Genetic Polymorphisms of CYP2C9: Comparison of prevalence in the Lebanese population with other populations","author":"Saab","year":"2011","journal-title":"Pharmacol Pharm"},{"key":"key-10.4103\/0028-3886.156281-17","first-page":"37","volume-title":"Different pharmacokinetic parameters of PHT in Iranian Outpatients: Need to optimize the current dosage administration","author":"Salehifara","year":"2009","journal-title":"Iran J Pharm Res"},{"key":"key-10.4103\/0028-3886.156281-18","first-page":"155","volume-title":"Influence of aging on serum phenytoin concentrations: A pharmacokinetic analysis based on therapeutic drug monitoring data","author":"Battino","year":"2004","journal-title":"Epilepsy Res"},{"key":"key-10.4103\/0028-3886.156281-19","first-page":"285","volume-title":"No gender effect on binding characteristics of PHT to serum proteins in monotherapy for adult patients with epilepsy","author":"Kodama","year":"2000","journal-title":"Am J Ther"},{"key":"key-10.4103\/0028-3886.156281-20","first-page":"301","volume-title":"Age and phenytoin kinetics in adult epileptics","author":"Bauer","year":"1982","journal-title":"Clin Pharmacol Ther"},{"key":"key-10.4103\/0028-3886.156281-21","first-page":"304","volume-title":"Therapeutic drug monitoring pattern of the antiepileptic drugs in developed and developing countries","author":"Prakash","year":"2009","journal-title":"Neurosciences"}],"container-title":["Neurology India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:29:30Z","timestamp":1786649370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.156281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"alternative-id":["156281"],"URL":"https:\/\/doi.org\/10.4103\/0028-3886.156281","relation":{},"ISSN":["0028-3886"],"issn-type":[{"value":"0028-3886","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}